HOME >> MEDICINE >> NEWS
New study reveals attempted suicide often a snap decision fuelled by drugs and alcohol

ohol abuse, feelings of rejection, self-hatred and disconnectedness."

Dr Wyder hopes the study gives counsellors and health professionals, as well as families, friends and loved ones, an insight into the complex set of risk factors and motives behind self-harming behaviour.

"It's important to understand the differences between those who attempt and those who die by suicide. Suicide and attempted suicide all share intentional or deliberate self-harming characteristics, but differ in the outcome," she says.

"These findings will contribute to the NSW Health framework for suicide risk assessment and management - helping to alleviate the immediate stress felt by patients, and providing help for the underlying factors once the suicidal feelings subside.

"The majority of people who attempt to harm themselves don't want to end their life, they just want a better life. If we're able to support both groups with more appropriate strategies, we may be able to lessen some of their pain."


'"/>

Contact: Amanda Whibley
61-296-787-084
Research Australia
18-Oct-2005


Page: 1 2 3

Related medicine news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New study shows promise in reducing surgical risks associated with surgical bleeding
4. New study counts the economic cost of persistent pain in Australia
5. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
6. Most seniors now have drug coverage, U-M study shows
7. To gain muscle and lose fat, drink milk: study
8. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
9. Even older women at high risk have little interest in being tested for HIV, study finds
10. Metabolic study in mice could lead to good cholesterol boosters
11. Michigan-CDC study supports value of social restrictions during influenza pandemics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/28/2017)... (PRWEB) , ... July 28, 2017 , ... Kevin Harrington, one of the original Sharks ... announce the launch of a new DRTV campaign with My Real Earth. , Most people ... our bodies is just as important as what we put in our bodies. After all, ...
(Date:7/28/2017)... ... July 28, 2017 , ... For over 20 years Sealy Baby has been ... babies. We take tremendous pride in using some of nature’s best materials while integrating ... and innovative crib mattresses and crib bedding for infants and ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... through an alliance of independent physicians, has launched a new educational series of ... Jersey’s new regulations governing the prescribing of pain medication. The first two episodes ...
(Date:7/27/2017)... ... July 27, 2017 , ... Patients with ... in a single office visit from Dr. Alejandro Kovacs. Dr. Kovacs is a ... East Texas patients, including Teeth-in-a-Day® dental implants in Longview, TX. ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... Verification to State Medicaid programs, Managed Care Organizations and Home Care Agencies, has ... The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies and multiple ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
(Date:7/11/2017)...  The global market for liquid biopsy diagnostic and ... in 2016.  Although in early stages, the global market ... as a result of the gradual shift towards personalized ... of a significant number of new liquid biopsy tests ... biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology:
Cached News: